{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:38:57Z","timestamp":1790519937490,"version":"4.1.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"11-12","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Smallpox has been eradicated but advances in synthetic biology have increased the risk of its re-emergence. Residual immunity in individuals who were previously vaccinated may mitigate the impact of an outbreak, but there is a high degree of uncertainty about the duration and degree of residual immunity. Both cell-mediated and humoral immunity are thought to be important but the exact mechanisms of protection are unclear. Guidelines usually suggest vaccine-induced immunity wanes to zero after 3\u201310 years post vaccination, whereas other estimates show long term immunity over decades.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A systematic review of the literature was conducted to quantify the duration and extent of residual immunity to smallpox after vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-nine papers related to quantifying residual immunity to smallpox after vaccination were identified: neutralizing antibody levels were used as immune correlates of protection in 11\/16 retrospective cross-sectional studies, 2\/3 epidemiological studies, 6\/7 prospective vaccine trials and 0\/3 modeling studies. Duration of protection of &amp;gt;20 years was consistently shown in the 16 retrospective cross-sectional studies, while the lowest estimated duration of protection was 11.7 years among the modeling studies. Childhood vaccination conferred longer duration of protection than vaccination in adulthood, and multiple vaccinations did not appear to improve immunity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most studies suggest a longer duration of residual immunity (at least 20 years) than assumed in smallpox guidelines. Estimates from modeling studies were less but still greater than the 3\u201310 years suggested by the WHO Committee on International Quarantine or US CDC guidelines. These recommendations were probably based on observations and studies conducted while smallpox was endemic. The cut-off values for pre-existing antibody levels of &amp;gt;1:20 and &amp;gt;1:32 reported during the period of endemic smallpox circulation may not be relevant to the contemporary population, but have been used as a threshold for identifying people with residual immunity in post-eradication era studies. Of the total antibodies produced in response to smallpox vaccination, neutralizing antibodies have shown to contribute significantly to immunological memory. Although the mechanism of immunological memory and boosting is unclear, revaccination is likely to result in a more robust response. There is a need to improve the evidence base for estimates on residual immunity to better inform planning and preparedness for re-emergent smallpox.<\/jats:p><\/jats:sec>","DOI":"10.1093\/milmed\/usz181","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T12:10:35Z","timestamp":1564661435000},"page":"e668-e679","source":"Crossref","is-referenced-by-count":18,"title":["Evidence for Residual Immunity to Smallpox After Vaccination and Implications for Re-emergence"],"prefix":"10.1093","volume":"184","author":[{"given":"Mohana Priya","family":"Kunasekaran","sequence":"first","affiliation":[{"name":"Kirby Institute, Faculty of Medicine, University of New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Kirby Institute, Faculty of Medicine, University of New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Costantino","sequence":"additional","affiliation":[{"name":"Kirby Institute, Faculty of Medicine, University of New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar Ahmad","family":"Chughtai","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandini Raina","family":"MacIntyre","sequence":"additional","affiliation":[{"name":"Kirby Institute, Faculty of Medicine, University of New South Wales, Australia"},{"name":"College of Public Service and Community Solutions, Arizona State University, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"issue":"9624","key":"2019121323371760100_usz181C1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(08)60424-9","article-title":"A new global malaria eradication strategy","volume":"371","author":"Feachem","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"2019121323371760100_usz181C2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-9433-4-2","article-title":"The future of smallpox vaccination: is MVA the key?","volume":"4","author":"Slifka","year":"2005","journal-title":"Med Immunol"},{"key":"2019121323371760100_usz181C3","author":"World Health Organization (WHO)"},{"key":"2019121323371760100_usz181C4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan7069","article-title":"How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA","author":"Kupferschmidt","year":"2017","journal-title":"Science"},{"issue":"1","key":"2019121323371760100_usz181C5","doi-asserted-by":"crossref","first-page":"e0188453","DOI":"10.1371\/journal.pone.0188453","article-title":"Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments","volume":"13","author":"Noyce","year":"2018","journal-title":"PLoS One"},{"key":"2019121323371760100_usz181C6","volume-title":"Smallpox and Its Eradication: The Pathogenesis, Immunology, and Pathology of Smallpox and Vaccinia","author":"Fenner","year":"1988"},{"key":"2019121323371760100_usz181C7","volume-title":"A Continuation of Facts and Observations Relative to the Variolae Vaccinae, or Cow Pox","author":"Jenner","year":"1800"},{"key":"2019121323371760100_usz181C8","volume-title":"The Origin of the Vaccine Inoculation","author":"Jenner","year":"1801"},{"issue":"5597","key":"2019121323371760100_usz181C9","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.1074674","article-title":"Containing bioterrorist smallpox","volume":"298","author":"Halloran","year":"2002","journal-title":"Science"},{"issue":"4","key":"2019121323371760100_usz181C10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10729-005-4138-4","article-title":"The effect of social mixing controls on the spread of smallpox \u2013 a two-level model","volume":"8","author":"Kress","year":"2005","journal-title":"Health Care Manag Sci"},{"key":"2019121323371760100_usz181C11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2334-10-25","article-title":"Contingency planning for a deliberate release of smallpox in Great Britain \u2013 the role of geographical scale and contact structure","volume":"10","author":"House","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2019121323371760100_usz181C12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present, and future","volume":"118","author":"Parrino","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"2019121323371760100_usz181C13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"2019121323371760100_usz181C14","first-page":"718","volume-title":"Vaccines","author":"Kennedy","year":"2012","edition":"6th Edition"},{"issue":"4","key":"2019121323371760100_usz181C15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3201\/eid2404.171233","article-title":"Influence of population immunosuppression and past vaccination on smallpox reemergence","volume":"24","author":"MacIntyre","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2019121323371760100_usz181C16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"33","key":"2019121323371760100_usz181C17","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.vaccine.2012.05.049","article-title":"Immune markers and correlates of protection for vaccine induced immune responses","volume":"30","author":"Thakur","year":"2012","journal-title":"Vaccine"},{"issue":"28","key":"2019121323371760100_usz181C18","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.vaccine.2016.05.005","article-title":"Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients","volume":"34","author":"Kennedy","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"2019121323371760100_usz181C19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"2019121323371760100_usz181C20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"04","key":"2019121323371760100_usz181C21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0950268813000071","article-title":"Pertussis resurgence: waning immunity and pathogen adaptation \u2013 two sides of the same coin","volume":"142","author":"Mooi","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"11","key":"2019121323371760100_usz181C22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/oxfordjournals.aje.a009951","article-title":"Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity","volume":"150","author":"Mossong","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2019121323371760100_usz181C23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1098\/rspb.2009.0057","article-title":"Implications of vaccination and waning immunity","volume":"276","author":"Heffernan","year":"2009","journal-title":"Proc R Soc Lond B: Biol Sci"},{"issue":"6","key":"2019121323371760100_usz181C24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrmicro1845","article-title":"Mathematical models of infectious disease transmission","volume":"6","author":"Grassly","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2019121323371760100_usz181C25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/rmv.443","article-title":"An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it","volume":"14","author":"Bernoulli","year":"2004","journal-title":"Rev Med Virol"},{"issue":"2","key":"2019121323371760100_usz181C26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2006.03.002","article-title":"Containing a large bioterrorist smallpox attack: a computer simulation approach","volume":"11","author":"Longini","year":"2007","journal-title":"Int J Infect Dis"},{"key":"2019121323371760100_usz181C27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: what is \u201cimmunosenescence\u201d?","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp Gerontol"},{"issue":"2","key":"2019121323371760100_usz181C28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2188\/jea.14.41","article-title":"Modeling for a smallpox-vaccination policy against possible bioterrorism in Japan: the impact of long-lasting vaccinal immunity","volume":"14","author":"Nishiura","year":"2004","journal-title":"J Epidemiol"},{"issue":"6","key":"2019121323371760100_usz181C29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/122.6.479","article-title":"Variola major in West Pakistan","volume":"122","author":"Mack","year":"1970","journal-title":"J Infect Dis"},{"issue":"5","key":"2019121323371760100_usz181C30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.15-0185","article-title":"Immunocompromised travelers: demographic characteristics, travel destinations, and pretravel health care from the US Global TravEpiNet Consortium","volume":"93","author":"Schwartz","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"2019121323371760100_usz181C31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2019121323371760100_usz181C32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int J Celiac Dis"},{"issue":"4","key":"2019121323371760100_usz181C33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.01.011","article-title":"Immunosenescence: implications for vaccination programmes in adults","volume":"68","author":"Lang","year":"2011","journal-title":"Maturitas"},{"issue":"5","key":"2019121323371760100_usz181C34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11427-013-4478-0","article-title":"Immunosenescence and age-related viral diseases","volume":"56","author":"Ma","year":"2013","journal-title":"Sci China Life Sci"},{"key":"2019121323371760100_usz181C35","author":"Global Observatory on Donation and Transplantation"},{"key":"2019121323371760100_usz181C36","author":"Global Observatory on Donation and Transplantation"},{"issue":"11","key":"2019121323371760100_usz181C37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2471\/BLT.14.137653","article-title":"The global diffusion of organ transplantation: trends, drivers and policy implications","volume":"92","author":"White","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"4","key":"2019121323371760100_usz181C38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analysis: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"2019121323371760100_usz181C39","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2019121323371760100_usz181C40","volume-title":"Cochrane Methods. Cochrane Database of Systematic Reviews","author":"Higgins","year":"2016"},{"issue":"10","key":"2019121323371760100_usz181C41","doi-asserted-by":"crossref","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"issue":"04","key":"2019121323371760100_usz181C42","first-page":"466","article-title":"The antibody response in man following infection with viruses of the pox group: II. Antibody response following vaccination","volume":"56","author":"McCarthy","year":"1958","journal-title":"J Hyg"},{"issue":"3","key":"2019121323371760100_usz181C43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"El-Ad","year":"1990","journal-title":"J Infect Dis"},{"issue":"9","key":"2019121323371760100_usz181C44","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1128\/JCM.41.9.4068-4070.2003","article-title":"Smallpox: residual antibody after vaccination","volume":"41","author":"Gallwitz","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2019121323371760100_usz181C45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"2019121323371760100_usz181C46","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1099\/vir.0.81265-0","article-title":"Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy","volume":"86","author":"P\u00fctz","year":"2005","journal-title":"J Gen Virol"},{"issue":"12","key":"2019121323371760100_usz181C47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"issue":"3","key":"2019121323371760100_usz181C48","doi-asserted-by":"crossref","first-page":"e33392","DOI":"10.1371\/journal.pone.0033392","article-title":"A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2019121323371760100_usz181C49","doi-asserted-by":"crossref","first-page":"e0169247","DOI":"10.1371\/journal.pone.0169247","article-title":"Humoral immunity to primary smallpox vaccination: impact of childhood versus adult immunization on vaccinia vector vaccine development in military populations","volume":"12","author":"Slike","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"2019121323371760100_usz181C50","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"issue":"8","key":"2019121323371760100_usz181C51","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells","volume":"78","author":"Amara","year":"2004","journal-title":"J Virol"},{"issue":"11","key":"2019121323371760100_usz181C52","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-\u03b3\u2013producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"2019121323371760100_usz181C53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/380460","article-title":"Age distribution for T cell reactivity to vaccinia virus in a healthy population","volume":"38","author":"Hsieh","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2019121323371760100_usz181C54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1469-0691.2006.01576.x","article-title":"The persistence of humoral and cellular immunities more than three decades after smallpox vaccination","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"2019121323371760100_usz181C55","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"2019121323371760100_usz181C56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/oxfordjournals.aje.a121319","article-title":"A study of inapparent infection in smallpox","volume":"94","author":"Heiner","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2019121323371760100_usz181C57","doi-asserted-by":"crossref","first-page":"e0157335","DOI":"10.1371\/journal.pone.0157335","article-title":"A randomized, double-blind, placebo-controlled phase ii trial investigating the safety and immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN\u00ae) in 56-80-year-old subjects","volume":"11","author":"Greenberg","year":"2016","journal-title":"PLoS One"},{"issue":"45","key":"2019121323371760100_usz181C58","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1016\/j.vaccine.2015.09.067","article-title":"Freeze-dried live attenuated smallpox vaccine prepared in cell culture \u201cLC16-KAKETSUKEN\u201d: Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice","volume":"33","author":"Nishiyama","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"2019121323371760100_usz181C59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/524078","article-title":"Persistence of vaccinia at the site of smallpox vaccination","volume":"46","author":"Cummings","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2019121323371760100_usz181C60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"2019121323371760100_usz181C61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0264-410X(98)00197-2","article-title":"Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination","volume":"17","author":"Stienlauf","year":"1999","journal-title":"Vaccine"},{"issue":"7","key":"2019121323371760100_usz181C62","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/423851","article-title":"Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus","volume":"190","author":"Orr","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"2019121323371760100_usz181C63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2019121323371760100_usz181C64","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox","volume":"52","author":"Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"4","key":"2019121323371760100_usz181C65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/oxfordjournals.aje.a121326","article-title":"A study of intrafamilial transmission of smallpox","volume":"94","author":"Heiner","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2019121323371760100_usz181C66","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.ede.0000229196.41862.c2","article-title":"Still protected against smallpox?: estimation of the duration of vaccine-induced immunity against smallpox","volume":"17","author":"Nishiura","year":"2006","journal-title":"Epidemiology"},{"issue":"5","key":"2019121323371760100_usz181C67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s15010-006-6603-5","article-title":"Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure","volume":"34","author":"Nishiura","year":"2006","journal-title":"Infection"},{"issue":"8","key":"2019121323371760100_usz181C68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/aje\/kwg225","article-title":"Analysis of historical data suggests long-lasting protective effects of smallpox vaccination","volume":"158","author":"Eichner","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"433","key":"2019121323371760100_usz181C69","doi-asserted-by":"crossref","first-page":"eaao5945","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"2019121323371760100_usz181C70","first-page":"257","article-title":"Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses \u2013 recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015","volume":"65","author":"Petersen","year":"2016","journal-title":"MMWR"},{"issue":"10","key":"2019121323371760100_usz181C71","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.humimm.2013.06.031","article-title":"Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals","volume":"74","author":"Haralambieva","year":"2013","journal-title":"Hum Immunol"},{"key":"2019121323371760100_usz181C72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/gene.2016.15","article-title":"An interaction quantitative trait loci tool implicates epistatic functional variants in an apoptosis pathway in smallpox vaccine eQTL data","volume":"17","author":"Lareau","year":"2016","journal-title":"Genes Immun"},{"issue":"1","key":"2019121323371760100_usz181C73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2012.08.021","article-title":"Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination","volume":"510","author":"Ovsyannikova","year":"2012","journal-title":"Gene"},{"issue":"3","key":"2019121323371760100_usz181C74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4236\/aim.2016.63017","article-title":"Polyfunctional T cell and neutralizing antibody responses to ACAM2000TM smallpox vaccine immunization in primary-vaccinated individuals","volume":"6","author":"Sukhumvittaya","year":"2016","journal-title":"Adv Microbiol"},{"issue":"2","key":"2019121323371760100_usz181C75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/phn.12208","article-title":"Vaccination\u2010related side effects, humoral immunity, and adverse events during the Civilian Smallpox Vaccination Campaign, Arkansas, 2003","volume":"33","author":"Haselow","year":"2015","journal-title":"Public Health Nurs"},{"issue":"41","key":"2019121323371760100_usz181C76","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.vaccine.2015.08.032","article-title":"Sex difference in immune response to vaccination: a participant-level meta-analysis of randomized trials of IMVAMUNE\u00ae smallpox vaccine","volume":"33","author":"Troy","year":"2015","journal-title":"Vaccine"},{"issue":"17","key":"2019121323371760100_usz181C77","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"2019121323371760100_usz181C78","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00040-09","article-title":"Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model","volume":"16","author":"Meseda","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"2019121323371760100_usz181C79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vaccines6010008","article-title":"Challenges and achievements in prevention and treatment of smallpox","volume":"6","author":"Melamed","year":"2018","journal-title":"Vaccines"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/11-12\/e668\/31510162\/usz181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/11-12\/e668\/31510162\/usz181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T19:39:37Z","timestamp":1610739577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/184\/11-12\/e668\/5542515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":79,"journal-issue":{"issue":"11-12","published-online":{"date-parts":[[2019,8,1]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usz181","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,8,1]]}}}